FLUMAZENIL 0.5 MG/5 ML VIAL
For 5 mL
Pharmacies pay
$5.90 filed
5 × $1.17913 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-19 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$8.27 filed
5 × $1.65357 per ML, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
1.4× estimated
Medicare paid 1.4× what pharmacies pay.
Part D averages every strength and form sold under “Flumazenil” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-08-19 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$11.79 estimated
$5.90 + $0.89 (15%) + $5.00 fee per fill = $11.79
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-08-19 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
FLUMAZENIL 0.5 MG/5 ML VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as flumazenil.
FDA gives its dosage form as “injection, solution” and “injection” and its route as intravenous.
Its labelers, the companies named on the label, are Hikma Pharmaceuticals USA Inc., Baxter Healthcare Corporation and Fresenius Kabi USA, LLC.
FDA’s Established Pharmacologic Class for it is Benzodiazepine Antagonist.
The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $5.90 for 5 mL (5 × $1.17913 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-08-19. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size.
The NADAC of all 4 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-08-19. The file is new; the price is not.
What NADAC measures · NADAC explanation codes · Carried-forward prices
All 4 NDCs
- 00143-9684-10 · Hikma Pharmaceuticals USA Inc. · $1.17913 per ML · eff. 2026-08-19 filed carried forward
- 00143-9784-10 · Hikma Pharmaceuticals USA Inc. · $1.17913 per ML · eff. 2026-08-19 filed carried forward
- 36000-0148-10 · Baxter Healthcare Corporation · $1.17913 per ML · eff. 2026-08-19 filed carried forward
- 63323-0424-05 · Fresenius Kabi USA, LLC · $1.17913 per ML · eff. 2026-08-19 filed carried forward
What Medicare paid
Medicare Part D paid $8.27 for 5 mL, at an average of $1.65357 per ML in 2024 (2024-01-01 to 2024-12-31) for “Flumazenil”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 6,025 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 5 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 5 mL; your package may hold a different amount.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for FLUMAZENIL 0.5 MG/5 ML VIAL labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Flumazenil / Flumazenil: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on generic name.
- Why does this page start at 5 mL?
- NADAC prices this product per ML. In the FDA NDC Directory, 4 of this product’s NDCs are wholesale packs of identical units, so OpenBill counts one unit of each; for example, NDC 00143-9684-10 (“10 VIAL, MULTI-DOSE in 1 BOX (0143-9684-10) / 5 mL in 1 VIAL, MULTI-DOSE (0143-9684-01)”) is a box of 10 vials, 50 mL in all. So the card starts at one unit: 5 ML. Change it to match your prescription.